Abdominal aorta aneurysm screening program in Swietokrzyskie Voivodeship: early results by Żelezik, Marcin Piotr et al.
140 www.journals.viamedica.pl/acta_angiologica
Acta Angiol
Vol. 25, No. 2, pp. 140–144
Doi: 10.5603/AA.2019.0012
Copyright © 2019 Via Medica
ISSN 1234–950X
www.journals.viamedica.pl/acta_angiologica
ORIGINAL ARTICLE
Address for correspondence: Marcin Piotr Żelezik, Jan Kochanowski University, The Faculty of Medicine and Health Sciences, Kielce,  
Poland, e-mail: marcinzelezik@gmail.com
Abdominal aorta aneurysm screening program  
in Swietokrzyskie Voivodeship: early results
Marcin Piotr Żelezik1, Anna Michalska1, Kinga Kapturska1, Aleksandra Michalska1,  
Alicja Niewiadomska1, Jarosław Miszczuk2, Marcin Sadowski1
1Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland 
2Department of Vascular Surgery, Provincial Hospital in Kielce, Swietokrzyskie Voivodeship, Kielce, Poland
Abstract 
Introduction: The prevalence of abdominal aorta aneurysms (AAA) is estimated to be between 1.3–12.5% 
in men and 5.2% in women, which poses a serious public health issue. Ruptured aorta aneurysm most often 
causes internal bleeding and ultimately leads to death. The cause of high mortality is the asymptomatic oc-
currence of AAA. Usually, the first symptom is its rupture
The aim of our paper is to provide a relationship between the percentage of the population reporting to the 
vascular surgeon and the type of residence based on the analysis of data from screening studies carried out in 
one of the regions of Poland.
Material and methods: Patients previously informed about the free diagnostics in the Provincial Hospital in 
Kielce were examined by qualified physicians with ESAOTE MyLab Seven ultrasound device. Prior to that, patients 
were asked to fill a questionnaire to acquire data about their risk factors, demography, and medical history.
Results: A total of 22 (7.3%) aneurysms were found in a group of 301 patients, of which 20 (6.6%) were 
found in men and 2 (0.66%) in women. 
Conclusions: Screening tests are an effective method to significantly improve early detection of AAAs. However, 
it is necessary to provide easier access to health professionals qualified to perform ultrasound examinations. 
It is especially important for the population of men with a family history of AAA, because they are at a higher 
risk of developing this pathology. The incidence rate of AAA observed in our study is consistent with the data 
published in worldwide literature.
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Introduction
The prevalence of abdominal aorta aneurysms 
(AAA) is estimated to be between 1.3–12.5% in men 
and 5.2% in women, which poses a serious public health 
issue [1, 2]. The dilatation of the aorta meeting the AAA 
criteria is a localized, continuous increase in the diame-
ter of the vessel by 50% relative to its normal diameter 
or by 3 cm and more [3]. Nearly 80% of patients with 
AAA rupture die before they get to the hospital, while 
in-hospital mortality rate in patients with established 
AAA diagnosis is about 50% [3, 4]. Among the risk 
factors for the development of AAA are age, gender, hy-
pertension, positive family history and coronary artery 
 disease [5]. Diabetes seems to have a protective effect 
on the formation of AAA [6, 7]. One of the causes of 
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high mortality is the asymptomatic occurrence of AAA. 
Usually, its first symptom is a rupture. Mortality associ-
ated with planned open surgery of the aortic aneurysm 
ranges from 3% to 6%, and perioperative mortality 
in patients with AAA rupture is 60–80%. That is why 
in most cases the aortic aneurysm surgery is done by 
endovascular repair with a mortality rate of 1–2% [8]. 
Early diagnosis and implemented treatment can protect 
patients from life-threatening consequences [9]. The 
implementation of AAA screening led to a reduction 
in mortality in the population observed [10–12]. So 
far, there has been no quantitative data about the de-
velopment of AAA among the inhabitants of rural and 
urban areas. It is now known that the mental state of 
patients who are aware of their life-threatening pathol-
ogy can lead to emotional disturbances, deterioration 
of the quality of life and hinders social and professional 
activity [13]. The aim of our paper is to determine the 
relationship between the percentage of the population 
reporting to the vascular surgeon and their place of 
residence based on the analysis of data from screening 
studies carried out in one of the regions of Poland.
Material and methods
Patients previously informed about the free dia-
gnostics in the Provincial Hospital in Kielce, were 
examined by qualified physicians with ESAOTE MyLab 
Seven ultrasound device. Prior to that, patients were 
asked to fill a questionnaire to acquire data about their 
risk factors, demography, and medical history (Fig. 1). 
The screening was held in rooms of the Department 
of Vascular Surgery. On arrival, the physician explained 
the procedures to the patient, checked their question-
naire, and answered queries. Signed informed consent 
was obtained. 
Then, the patient had an ultrasound scan of the 
abdominal aorta. The maximum transverse diameter 
of the aorta in the transverse plane and the maximum 
anteroposterior diameter in the longitudinal plane 
were measured with calipers on the device and noted 
by a medical student in the appropriate text box in pa-
tients’ screening program documentation. The largest 
diameter of these two readings was recorded as the 
maximum aortic diameter for each patient (Fig. 2). 
After that procedure, the scanned group was divided 
into two groups: those who had an abdominal aortic 
aneurysm, and those in whom no aneurysm was de-
tected. The first group was given a referral to their 
family doctors, for follow up, at intervals related to the 
aortic size. All data had been transcribed to Excel file 
and then database operations have been performed. 
Statistics were calculated using Statistica 13 StatSoft 
Software. 
Results
A total of 22 (7.3%) aneurysms were found in 
a group of 301 patients, of which 20 (6.6%) were found 
in men and 2 (0.66%) in women. Both women had no 
history of smoking, had a history of coronary artery 
disease, suffered from high blood pressure and hyper-
lipidemia, and were not diabetic. One of the patients 
had a positive family history of aneurysm. The diameters 
of the AAA’s were 42.7 mm and 32 mm.
In the group of men, a correlation between coro-
nary disease, smoking, hyperlipidemia, diabetes and the 
occurrence of AAAs was not significant. A correlation 
between familial occurrence of AAAs and the occur-
rence of AAAs in patients was observed, OR = 9.00 
(95% CI 2.0507 to 39.4988), p = 0.0036. In this group, 
most AAA’s (n = 14) were of a diameter range of 30–35 
mm. Additionally, there was one of 46 mm, 53 mm, 
41.9 mm and 44.6–50.3 (on 10 cm length). We found 
also dilatation in iliac arteries ranging 15.2–50 mm in 
a left common iliac artery (LCIA) and 16.9–32 mm in 
right common iliac artery (RCIA) (Tables 1–3, Fig. 3).
Discussion
Screening tests for abdominal aortic aneurysms 
are performed on patients fulfilling at least three of 
the following criteria: (1) age above 65 years, (2) 
male, (3) hypertension, (4) coronary artery disease, 
(5) hyperlipidemia, (6) smoking or (7) negative family 
history [14–16]. According to recent reports, the risk 
of developing AAA is higher in the first degree relatives 
of AAA patients, regardless of sex, in comparison to 
those without a family history of AAA [17]. This suggests 
that patients of both sexes above the age of 65 with 
a positive family history of AAA should be screened. 
In women within the risk group, there is a need for 
prophylactic screening, due to the higher risk of death 
following rupture of the aneurysm (88%, p = 0.001), 
despite a twice lower risk of AAA development (p = 
0.009) compared with men [18]. Based on the results 
of our research, we are unable to present a correlation 
between the risk factors and the development of AAA in 
female patients we examined. It is probably the result of 
a smaller percentage of women taking part in the study 
compared with men and a low number of women with 
AAA in this group (n = 2; 0.66%). Research shows that 
the most important risk factors of developing AAA in 
women are: (1) coronary artery disease [19], (2) hy-
pertension and (3) hyperlipidemia [20]. 
The early results of this study correspond with 
papers covering a similar problem. The percentages 
we observed in the Swietokrzyskie Voivodeship are in 
accordance with observations made during the study 
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Figure 1. Questionnaire
Figure 2. Screening record
Nationwide abdominal aortic aneurysm screening program 
2018–2020
Please answer the following questions which help us  
identify risk factors
Yes No
Age greater than or equal to 65
Coronary artery disease
Smoking
Hypertension*
*If yes, is it treated?...........................
Dyslipidaemia
Sex Women Men
BMI: Weight: Height:
Cardiovascular diseases  ......................................................
Previous surgical treatment  ................................................
Hernia  .................................................................................
Chronicobstructivepulmonarydisease  ................................
Other significant diseases  ...................................................
Injuries  ................................................................................
Family history of aneurysm*  ...............................................
*If yes — which artery  .......................................................
Examination number  ..........................................................
Full name  ............................................................................
Sex  ......................................................................................
Patient ID  ............................................................................
Date of birth/age  ................................................................
Address  ...............................................................................
Telephone number  .............................................................
Medical history:
Family history  .....................................................................
Previous treatment  .............................................................
Risk factors: coronary artery disease, smoking, hypertension, 
hyperlipidemia, male*
*Mark appropriate
Clinical examination:
USG device used:  ...............................................................
Description:
The study included the abdominal aorta, its division,  
and common iliac arteries
The aneurysmal dilatation of abdominal aorta and/or iliac  
arteries was found/not found.*
*Mark appropriate
Max. diameter of the aorta
Max. diameter of iliac arteries R: L:
Control ultrasound examination of the abdominal aorta and 
iliac arteries for 6 months is indicated/ not indicated.*
*Mark appropriate
A referral to the hospital/information to the general practi-
tioner was issued/not issued.*
*Mark appropriate
Comments:  .......................................................................
Table 1. Risk factors and diameter of abdominal aorta dilatation in 
population of women in the study
No Risk factors Aneurysm  
diameter
1 Coronary artery disease, hypertension,  
hyperlipidemia
42.7 mm
2 Coronary artery disease, hypertension,  
hyperlipidemia, family history  
of aneurysms
32 mm
performed in Grampian in 2012–2013 [21]. A compari-
son of the results shows a similar level of interest by 
the population. In large cities, it was 42.6%, in villages 
38.9%, in small towns — 18.5% and in mid-sized 
towns — 4%. Such a distribution might indicate an 
insufficient level of accessibility to health care in smaller 
towns and villages. 
Based on the above, we believe that the public in 
large cities is more aware of the risks of AAA and due 
to higher accessibility of hospitals and specialist care, the 
rate of detection is higher. According to Lesjak et al. [10], 
it is advisable to have mobile ultrasound device for AAA 
in areas with a population below 20,000 people, where 
accessibility of screening tests is limited [22, 23]. 
In a similar study, but based on a significantly bigger 
group, the results regarding the prevalence of AAA 
were similar to ours (7.2% of all screened patients) 
[24]. This stands in agreement with another study de-
scribed by Palombo et al. [25]. It also referred to the 
problem of decreasing the mortality rate by a successful 
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Table 2. Presence of risk factors in the study population
Women Men
BMI > 30 46 62
Smoking 18 21
Hyperlipidemia 127 143
Coronary artery disease 91 83
High BP 119 152
Family  history of aneurysms 20 8
Diabetes 29 40
Table 3. Distribution of patients according to their place  
of residence
Population  
(in thousands)
Place  
of residence
Number  
of patients
< 5 Village 65
5–20 Small towns 33
20–100 Mid-sized towns 12
> 100 Large cities 191
Total 301
0
2
4
6
8
10
12
14
16
18
20
Hypertension
Hyperlipidemia
Positive family 
history
Coronary artery 
disease
Diabetes
Smoking
Figure 3. Risk factors of abdominal aneurysms in population 
of men diagnosed with AAA
screening program, which will be discussed in our next 
paper with the follow-up.
The presence of AAA is usually symptom-free. The 
Polish Cardiac Society states that on rare occasions the 
symptoms might be abdominal or back pains. USG tests 
decrease the mortality rate in men in the long run [26] 
by 34% (RR, 0.66; 95% CI, 0.47–0.93; NNS, 311). This 
shows the effectiveness of screening examination for 
AAA using of USG devices. It is important to state that 
the larger size of the aneurysm and the possible later 
detection results in increased vascular complications 
and a more difficult repair of the aneurysm [27]. In older 
patients (> 80 years), the EVAR procedure survival rate 
is 2.53-fold lower ([HR] = 2.53; 95 [CI], 1.73–3.70; 
p < 0.001) [28]. Additionally, patients above the age of 
70 are at higher risk of post-operational complications 
than those below 70 years of age (10.7% vs. 7.0%, 
p = 0.007) [29]. 
Conclusion
During the pilot screening program, we confirmed 
the correlation between the family history of abdominal 
aorta aneurysm and a higher risk of its development. 
The incidence rate of AAAfound in our study is con-
sistent with the data available in worldwide literature. 
Our paper focused on early, sociological data, and we 
concluded that people from large cities are more likely 
to attend screening than those from rural areas. We 
hope that due to the regionalization of screening for 
AAA in cities and rural areas, the accessibility to tests 
done by experienced physicians will improve.
It is especially important, as early detection of AAA 
leads to a decreased risk of mortality and its treatment 
can lead to a higher quality of life. Therefore early de-
tection of AAA is crucial for the patients. 
More data and the follow-up will be published after 
the pilot study ends.
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